Extended Data Fig. 2 | Nature Medicine

Extended Data Fig. 2

From: Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study

Extended Data Fig. 2

Scatterplots showing a) difference in on-treatment HbA1c between pioglitazone and sitagliptin (negative values favour pioglitazone, positive values favour sitagliptin) against BMI, and b) difference in on-treatment HbA1c between sitagliptin and canagliflozin (negative values favour sitagliptin, positive values favour canagliflozin) against eGFR. Line of best fit shown for each plot.

Back to article page